Cova Pay is new software for cannabis stores designed to address current concerns of business owners.
In a recent press release (1), Cova Software announced the debut of Cova Pay, a new software designed to integrate with Cova Point of Sale (POS) and also remove the need for third party payment contracts by allowing cannabis retailers to process debit and credit cards directly through the POS (1). Cova Pay will use mobile, WiFi and LTE compatible terminals to supplement Cova Software’s tablet-based POS (1).
Cova Software, started in 2016, builds software for cannabis retail businesses in North America, including cannabis point of sale, eCommerce, payments, inventory management, and advanced analytics (1,2).
"As the Canadian cannabis market has matured, retailers have exposed the need for a next-level payment solution that isn't glitchy, failure-prone, or difficult when resolving issues,” said Gary Cohen, CEO of Cova Software (1).
References
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Khan
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
German Medical Cannabis Market Has Yet to Reach Its Full Potential
December 25th 2024Germany’s Cannabis Act (CanG) is beginning to transform the country's medical cannabis market, with potential opportunities to expand telemedicine, improve physician training, and enhancing accessibility in this rapidly growing industry.